// App-Quantinova.ai

AB1082 (2022) : FREQUENCY AND SEVERITY OF COVID-19 IN PATIENTS WITH VARIOUS RHEUMATIC DISEASES TREATED REGULARLY WITH COLCHICINE OR HYDROXYCHLOROQUINE

Researchers

Presenter

  • M. Oztas

Principal Investigators

  • M. Bektas

  • I. Karacan

  • N. Aliyeva

  • A. Dag

  • S. Aghamuradov

  • S. B. Cevirgen

  • S. Sari

  • M. Bolayirli

  • G. Can

  • G. Hatemi

  • E. Seyahi

  • H. Ozdogan

  • A. Gul

  • S. Ugurlu

Medical Centers

  • Istanbul University-Cerrahpasa,Department of Medicine, Division of Rheumatology, Istanbul, Turkey

  • Istanbul University-Cerrahpasa,Department of Medicine, Division of Rheumatology, Istanbul, Turkey

  • Bo?azici University, Department of Molecular Biology and Genetics, Istanbul, Turkey

  • Istanbul University-Cerrahpasa, Department of Biochemistry, Istanbul, Turkey

  • Istanbul University Cerrahpasa, Department of Pediatric Hematology, Istanbul, Turkey

Locations

  • Turkey

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Dermatology

  • Infectious Diseases (ID)

Disease

  • Familial Mediterranean fever

  • Lupus

  • Rheumatoid arthritis

  • Sjogren's syndrome

  • Behcet disease

  • Inflammatory Arthritis

  • Coronavirus disease

Biomarkers

  • Immunoglobulin G

Drug/Treatment

  • Hydroxychloroquine

  • Colchicine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved